Pharvaris’s Oral HAE Prevention Data May Threaten BioCryst’s Orladeyo

 
• By Joseph Haas
Oral vs injectable
Pharvaris hopes to compete with injectables and the other oral in HAE • Source: Shutterstock

More from Clinical Trials

More from R&D